Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…
Read More
Researchers Develop Novel Vitamin K Analogues as Potential Regenerative Therapy for Neurodegenerative Diseases
Researchers at the Shibaura Institute of Technology (SIT) in Japan have developed a novel vitamin K analogue that demonstrates significantly…
Read More
Rethinking evidence generation for ultra-rare diseases
Developing treatments for the approximately 7,000 known rare diseases, particularly the subset classified as ultra-rare, presents profound and often insurmountable…
Read More
China Ascends to Global Clinical Trial Leadership as Immunology and Metabolic Diseases Emerge as Key Growth Areas
As the global pharmaceutical industry navigates the dynamic landscape of clinical research, China has firmly established its dominance in trial…
Read More
Groundbreaking Drug Screening Platform Developed to Combat Neurological and Psychiatric Diseases by Targeting Protein Expression Imbalances
A pioneering drug screening platform has been successfully developed by researchers, designed to identify compounds that directly address the fundamental…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
TWiV 1292: Clinical Update with Dr. Daniel Griffin Examines Public Health Decline, Vaccine Policy Shifts, and Resurgent Infectious Diseases
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
Rethinking evidence generation for ultra-rare diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the inherent limitations of traditional…
Read More
LEO Pharma Acquires Gene Therapy Pioneer Replay to Revolutionize Treatment for Rare Genetic Dermatological Diseases
In a landmark move poised to redefine the landscape of dermatological therapeutics, LEO Pharma, a global leader in medical dermatology,…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
